Sharma, A. ., Subudhi, S. ., Blando, J. ., Scutti, J. ., Vence, L. ., Wargo, J. ., … Sharma, P. . (2018). Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.CCR-18-0762 (Original work published 2018)

Reilley, M. ., Bailey, A. ., , Janku, F. ., Naing, A. ., Falchook, G. ., … Hong, D. . Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Journal for Immunotherapy of Cancer, 5, 35. https://doi.org/10.1186/s40425-017-0238-1 (Original work published 2017)

Morris, V. ., Salem, M. ., Nimeiri, H. ., Iqbal, S. ., Singh, P. ., Ciombor, K. ., … Eng, C. . (2017). Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. The Lancet. Oncology, 18(4), 446-453. https://doi.org/10.1016/S1470-2045(17)30104-3